VERVE THERAPEUTICS - Key Persons
Job Titles:
- Senior Director, Internal Quality Control
Job Titles:
- Senior Associate, Supply Chain Management
Job Titles:
- Research Associate, Next Generation Sequencing
Job Titles:
- Associate Director, CMC Project Management
Job Titles:
- Senior Research Associate, MRNA Technology
Job Titles:
- Executive Director, Regulatory Strategy
Job Titles:
- Associate Director, Clinical Supplies and Logistics
Job Titles:
- Research Associate, Next Generation Sequencing
Job Titles:
- Director, Editing and Discovery
Job Titles:
- Senior Manager, External Quality Control
Job Titles:
- Senior Engineer, Technology Transfer and Process Engineering
Job Titles:
- Corporate Counsel
- Director
Job Titles:
- Scientist II, RNA Technology
Allison Dorval is the chief financial officer at Verve Therapeutics. She has more than 25 years of leadership experience in finance, accounting and investor relations, including 15 in the life sciences industry. Prior to joining Verve, Allison served as chief financial officer at Voyager Therapeutics. She has also served as vice president and controller of Juniper Pharmaceuticals and as a consultant at Danforth Advisors. She has held several leadership roles at Insulet Corporation, including chief financial officer. Earlier in her career, she served in corporate finance positions with iBasis, Inc. and Digitas Inc. Allison is a member of the Board of Directors at Aerovate Therapeutics and Puma Biotechnology.
Allison obtained a B.S. in Business Administration from the University of Vermont. She is a certified public accountant and began her career at PwC.
Job Titles:
- Senior Research Associate, Editor Development
Job Titles:
- Manager, External Quality Control
Job Titles:
- Vice President, Genomic Medicine
Job Titles:
- Clinical Trial Specialist
Job Titles:
- Associate Scientist, Editing Discovery
Andrew Ashe - Chief Legal Officer, COO, President
Job Titles:
- Chief Operating Officer
- General Counsel
- President
Andrew Ashe is the president, chief operating officer and general counsel at Verve Therapeutics. He is an accomplished biotech executive with over 20 years of experience in operations and legal management. Prior to joining Verve, Andrew served as a senior executive and general counsel for several biotechnology companies, most notably at Dyax Corp. where he managed legal, operations and administrative functions during a period of growth in which market capitalization increased from $180 million to $6 billion. He also established more than 75 revenue-generating collaborations with biotech and pharma companies in the United States, Europe, India, Australia, and Japan. Andrew remained with Dyax until it was acquired by Shire in 2016, after which he served as a consultant and as an executive at Applied Genetic Technologies Corporation. Previously, Andrew was a member of the business law practices at Prince Lobel Tye LLP and Nutter, McClennen & Fish LLP. Earlier in his career, he served as a trading specialist and senior analyst at the American and New York Stock Exchanges.
Andrew holds a B.A. in Finance from the Isenberg School of Management at the University of Massachusetts and a J.D. from the George Washington University School of Law.
Job Titles:
- Process Engineer, Formulation
Job Titles:
- Vice President, Information Technology
Job Titles:
- Senior Executive Assistant to the CEO
Job Titles:
- Executive Director, Analytics
Job Titles:
- Senior Director, Medical Writing
Job Titles:
- Senior Manager, Preclinical Pharmacology and Toxicology
Job Titles:
- Research Associate, Analytics
Job Titles:
- Scientist II, Computational Biology
Job Titles:
- Senior Research Associate, Editing Development
Job Titles:
- Associate Director, Process Sciences and Tech Transfer, Formulation Development
Job Titles:
- Senior Research Associate, RNA Technology
Job Titles:
- Analyst II, Quality Control
Job Titles:
- Vice President, Manufacturing and Supply
Job Titles:
- Member of the Compensation Committee
- Member of the Nominating and Corporate Governance Committee
- President and Chief Executive Officer, Solid Biosciences
Bo Cumbo has nearly three decades of pharmaceutical and biotechnology industry experience, including commercial launches of 11 specialty or rare disease drugs. He is currently president, chief executive officer and board member of Solid Biosciences. Previously, Bo served as president and chief executive officer of AavantiBio, Inc. Prior to AavantiBio, he held leadership positions at Sarepta Therapeutics, Inc., most recently as the executive vice president and chief commercial officer. Previously, Bo served as vice president of sales, key account management, and treatment educator teams at Vertex Pharmaceuticals. Earlier in his career, he served in multiple commercial roles supporting the HIV, HBV, and cardiovascular franchises at Gilead Sciences.
Bo holds a B.S. in Laboratory Technology from Auburn University.
Job Titles:
- Medical Writing Operations Specialist
Job Titles:
- Senior Scientist, Biophysical Characterization
Job Titles:
- Director, Pharmacology and Toxicology
Job Titles:
- Chairman of the Board
- Chairman of the Compensation Committee
- Chairman of the Nominating and Corporate Governance Committee
- Chairman of Compensation Committee / Chairperson of Nominating and Corporate Governance Committee
Chairman of the Board; former EVP and Chief Medical Officer, Dyax
Burt is a thought leader and expert in drug development with 32 years of experience in the biotechnology industry. He was most recently the executive vice president and chief medical officer at Dyax Corp, where he led development of lanadelumab (Takhzyro). Prior to Dyax, Burt held multiple leadership roles at Sesen Bio (formerly Eleven Biotherapeutics), most recently as interim president of research and development. Burt began his career at Biogen, where he held roles of increasing responsibility during a 16-year tenure, including vice president of regulatory affairs, executive vice president of research and development, and executive vice president of portfolio strategy. Burt is co-founder and chairman of Clear Creek Bio and a former member of the boards of directors of Sirona Medical Technologies and Catabasis Bio. He was special advisor to Novo Ventures (US) Inc. and the Novo Broad Greenhouse and is a past member of the investment committee of Partners (Mass General and Brigham and Women's Hospital) Investment Fund.
Burt holds a B.S. in Biology from Trinity College and an M.D. from Cornell Medical College. He completed residency training and a hematology fellowship at the Peter Bent Brigham Hospital
Job Titles:
- Senior Manager, Environmental, Health and Safety
Job Titles:
- Associate Director, RNA Technology and Engineering
Job Titles:
- Senior Research Associate, Mass Spectrometry
Job Titles:
- Scientist II, Process Development
Job Titles:
- Senior Engineer, Technology Transfer and Process Development
Job Titles:
- Director, Clinical Operations
Job Titles:
- Research Associate, Oligonucleotide Synthesis
Job Titles:
- Senior Associate, Quality Operations
Job Titles:
- Director, External Manufacturing
Job Titles:
- Associate Director, Clinical Operations
Job Titles:
- Associate Principal Scientist, Next Generation Sequencing
Job Titles:
- Manager, Metrology, Quality Control
Job Titles:
- Vice President, Process Development & RNA Technology
Job Titles:
- Senior Manager, External Quality Control
Job Titles:
- Associate Director, Laboratory, Quality Control
Job Titles:
- Scientist, Editor Development
Job Titles:
- Senior Scientist, Bioanalysis
Job Titles:
- Senior Research Associate, Preclinical Pharmacology
Job Titles:
- Senior Manager, Supply Chain Management
Job Titles:
- Chairman, Department of Genetics, University of Pennsylvania
Dr. Rader is the Seymour Gray Professor of Molecular Medicine and Chair of the Department of Genetics at the Perelman School of Medicine of the University of Pennsylvania. Daniel's research focuses on the human genetics and functional genomics of lipoprotein metabolism and atherosclerosis, as well as the translational implications for novel therapeutic approaches. He ‘rescued' an abandoned molecule that reduces cholesterol and led the successful development of this compound as a novel therapeutic for patients with homozygous familial hypercholesterolemia. He is known for his work in HDL metabolism and HDL function, as well as for his pioneering studies of novel biological pathways in lipid metabolism and cardiometabolic disease revealed through human genetics studies. He has been a champion of ‘genomic medicine' and its potential benefits in guiding preventive therapies.
Daniel trained in internal medicine at Yale and in lipidology, human genetics, and translational research at the National Heart Lung and Blood Institute. At Penn, he also serves as Chief of the Divisions of Human Genetics in the Departments of Medicine and Pediatrics and Associate Director of the Institute for Translational Medicine and Therapeutics, and he founded and directs the Penn Medicine BioBank, an integrated resource to support human genetics and translational research. He is a recipient of several national and international awards and has been elected to the National Academy of Medicine and the American Academy of Arts and Sciences.
Job Titles:
- in Vivo Study Coordinator
Job Titles:
- Associate Director, Pharmacokinetics and Biodistribution
Job Titles:
- Quality Assurance Auditor
Job Titles:
- Associate Director, Regulatory Affairs
Job Titles:
- Research Associate, Next Generation Sequencing
Job Titles:
- Senior Scientist, Protein Engineering
Job Titles:
- Senior Research Associate, Bioanalysis
Dr. Andrew Bellinger is the chief scientific officer at Verve Therapeutics. He is a cardiologist and scientist who specializes in company creation and growth, building high-performing research and development teams, translational medicine, drug delivery, and has a particular interest in the clinical development of novel classes of therapies. Prior to joining Verve, Andrew co-founded and served as chief scientific officer of Lyndra Therapeutics, and prior to that he was the chief scientific officer of Cocoon Biotech. He is also a co-founder of Corner Therapeutics. He previously practiced as an attending cardiologist at Brigham and Women's Hospital and is board-certified in cardiovascular medicine and internal medicine.
Andrew holds an M.D., a Ph.D., and an MPhil from Columbia University, an M.S. in mathematics from New York University, and an A.B. in physics from Princeton University. He completed his clinical training in internal medicine at the University of California, San Francisco, and his clinical training in cardiology at Brigham and Women's Hospital. He completed his postdoctoral research training in drug delivery with Dr. Robert Langer at the Massachusetts Institute of Technology.
Job Titles:
- Co - Founder and Chief Development Officer, Replicate Bioscience
Dr. Andrew Geall has over 20 years of experience developing drug delivery systems as a pioneer in mRNA vaccines and nucleic acid delivery. He currently serves as the chief development officer at Replicate Bioscience, which he cofounded. Prior to Replicate, Andrew was chief scientific officer at Precision NanoSystems Inc. He has also served as vice president of formulations, analytics and chemistry at Avidity Biosciences, RNA Vaccine Platform Leader at Novartis Vaccines, and Senior Fellow at Novartis Pharmaceuticals AG.
Andrew holds a pharmacy degree from the University of Bath in the United Kingdom and completed pre-registration training in the aseptic dispensing unit at St Helens and Knowsley Trust Hospitals. He obtained a Ph.D. at the University of Bath in non-viral gene delivery.
Job Titles:
- Chief Data Officer of the Broad Institute of MIT
- Chief Data Officer, Broad Institute of MIT and Harvard
Dr. Anthony Philippakis is the chief data officer of the Broad Institute of MIT and Harvard, and the co-director of the Eric and Wendy Schmidt Center. He trained as a cardiologist at Brigham and Women's Hospital, with a focus on rare genetic cardiovascular diseases. He is also a venture partner at GV, focused on machine learning, distributed computing, and genomics.
Anthony holds an M.D. from Harvard Medical School and a Ph.D. in Biophysics from Harvard. He received a B.S. in Mathematics from Yale University, and later completed the Part III (equivalent to M.Phil.) in mathematics at Cambridge University.
Job Titles:
- Chief Medical Officer, Stoke Therapeutics
Dr. Barry Ticho is a pediatric cardiologist who possesses deep knowledge of cardiovascular drug development and expertise in pharmacology, drug delivery and nucleic acid technologies. He currently serves as chief medical officer at Stoke Therapeutics. Prior to joining Stoke, Barry was head of development of mRNA treatments for cardiovascular and metabolic diseases at Moderna Therapeutics. Previously, he served as head of external research and development innovation for cardiovascular and metabolic diseases at Pfizer and, before that, was vice president of clinical development at Biogen. He has also served as a member of the clinical staff at Harvard Medical School.
Barry holds an M.D. and Ph.D. from the University of Chicago. He completed pediatrics training at Northwestern University and a cardiology fellowship at Boston Children's Hospital.
Job Titles:
- Cardiologist
- Distinguished Hersey Professor of Medicine at Harvard Medical School
Dr. Eugene Braunwald is a cardiologist at Brigham and Women's Hospital (BWH) and the distinguished Hersey professor of medicine at Harvard Medical School. During his career, Eugene has served as clinical director of the National Heart, Lung, and Blood Institute (NHLBI) and as chair of medicine at BWH for 24 years. He was also the founding chief academic officer of Partners Healthcare, and the founding chairman of the Thrombolysis in Myocardial Infarction Study Group, an academic research organization of BWH. He is also the first adult cardiologist elected to the National Academy of Medicine and received an honorary Doctor of Science from Oxford University.
Eugene received an M.D. from New York University. He completed an internal medicine residency at Johns Hopkins and a cardiology research fellowship in the laboratory of Nobelist André Cournand at Columbia University.
Dr. Fred T. Fiedorek is the chief medical officer (CMO) at Verve Therapeutics. He has more than 20 years of experience in clinical development and leadership, primarily in therapeutic areas such as diabetes, cardiovascular disease and endocrine/metabolic diseases. Prior to Verve, Fred held CMO roles at Rhythm Pharmaceuticals, Intarcia Therapeutics and a stealth company within Atlas Venture. In addition, he served as a senior advisor to Foresite Capital Management. Prior to these roles, he spent 13 years at Bristol-Myers Squibb (BMS), where he was most recently senior vice president, head of cardiovascular and metabolic development responsible for leading Phase 2 through Phase 4 global development for the cardiovascular and metabolic therapeutic areas. Under his leadership, several new medicines achieved successful marketing authorization, including Eliquis® (apixaban), Farxiga® (dapagliflozin), Onglyza® (saxagliptin) and Myalept® (metreleptin). Prior to BMS, Fred was international project leader for metabolic drug development at Glaxo-Wellcome.
Fred received an M.D. from Harvard Medical School and trained in internal medicine and endocrinology and metabolism at Washington University School of Medicine in St. Louis. He also served on the faculty at the University of North Carolina School of Medicine.
Dr. J. Keith Joung is a foremost expert on designer gene-editing tools and assessing and improving their safety. He currently holds the Robert B. Colvin, M.D., Endowed Chair in Pathology and is a pathologist at Massachusetts General Hospital, and a professor of pathology at Harvard Medical School. Keith has received numerous awards, including the 2022 Samsung Ho-Am Prize in Medicine, an NIH Director's Pioneer Award, an NIH Director's Transformative Research Project R01 Award, an NIH R35 MIRA (Maximizing Investigators Research Award), and election into the American Association of University Pathologists. He serves on the editorial boards of Cell Genomics, Human Gene Therapy, Genome Biology, and Trends in Biotechnology. He has co-founded and continues to advise multiple biotechnology companies, including Beam Therapeutics, Chroma Medicine, Editas Medicine, Nvelop Therapeutics, Pairwise Plants, and SeQure Dx.
Keith holds a Ph.D. in Genetics from Harvard University, an M.D. from Harvard Medical School, and an A.B. in Biochemical Sciences from Harvard College.
Job Titles:
- Professor of Cardiovascular Medicine and Genetics at the Perelman School of Medicine
- Professor of Cardiovascular Medicine and Genetics, Perelman School of Medicine at the University of Pennsylvania
Dr. Kiran Musunuru is a professor of cardiovascular medicine and genetics at the Perelman School of Medicine at the University of Pennsylvania. His research has earned him a number of awards, including the Presidential Early Career Award for Scientists and Engineers from the White House, the American Heart Association's Award of Meritorious Achievement and Joseph A. Vita Award, the American Philosophical Society's Judson Daland Prize for Outstanding Achievement in Clinical Investigation, and the American Federation for Medical Research's Outstanding Investigator Award. Before joining Penn Medicine, Kiran trained in internal medicine at Brigham and Women's Hospital and in cardiovascular medicine at Johns Hopkins Hospital, followed by postdoctoral work at Massachusetts General Hospital and the Broad Institute.
Kiran received an M.D. from Weill Cornell Medical College, a Ph.D. from the Rockefeller University, an MPH. from the Johns Hopkins Bloomberg School of Public Health, and an M.L. from the University of Pennsylvania Carey Law School.
Job Titles:
- Senior Vice President of Regulatory Affairs
Dr. Leslie Stolz is the senior vice president of regulatory affairs at Verve Therapeutics. She has more than two decades of experience in the life sciences industry, with extensive work in drug development across multiple therapeutic areas including immunology, cardiology, and rare diseases. Prior to joining Verve, Leslie was vice president, regulatory strategy at Syntimmune until it was acquired by Alexion in 2018. Previously, she held roles across regulatory, medical affairs, and medical communications at Shire, Dyax, and Boston Scientific.
Leslie holds a Ph.D. in Molecular Cancer Biology from Duke University and a B.S. in Biology from Villanova University. She was a postdoctoral fellow in the Department of Cardiovascular and Metabolic Diseases Research at Wyeth Research (now Pfizer).
Job Titles:
- Vice President, Non - Clinical Development
Job Titles:
- Associate Director, Benefits
Job Titles:
- Director, Enterprise Applications
Job Titles:
- Associate Principal Engineer, GRNA Process Development
Job Titles:
- Associate Director, Clinical Operations
Job Titles:
- Corporate Counsel
- Senior Director
Job Titles:
- Senior Contracts Specialist
Job Titles:
- Senior Scientist, Editing and Discovery
Job Titles:
- Senior Scientist, Mass Spectrometry
Job Titles:
- Scientist, Next Generation Sequencing
Job Titles:
- Manager, Regulatory Affairs
Job Titles:
- Senior Scientist, RNA / Oligonucleotide Chemistry
Job Titles:
- Scientist, Analytical Development
Job Titles:
- Associate Principal Scientist, Computational Biology
Job Titles:
- Manager, Next Generation Sequencing
Job Titles:
- Associate Principal Scientist, Editing & Discovery
Job Titles:
- Scientist II, Formulation
Job Titles:
- Senior Scientist, Analytics
Issi Rozen is a Venture Partner at GV, where he primarily focuses on the formation of new companies and early-stage investments. Issi is an experienced biotech executive and a serial entrepreneur who co-founded multiple startups, including GV portfolio company Verve Therapeutics. Previously, Issi spent a decade at the Broad Institute of MIT and Harvard, where he was the Institute's first Chief Business Officer and a member of the Executive Leadership Team. At the Broad, Issi led the creation of the Office of Strategic Alliances and Partnering and was responsible for developing innovative scientific and business collaborations, initiating and establishing new ventures around novel technologies, and overseeing strategy and licensing of the Institute's intellectual property portfolio. Issi played a key role in the creation and spin-out of over 20 startups from the Institute. Prior to joining the Broad, Issi led strategy and business development efforts at a number of biotech companies.
An accomplished jazz guitarist, Issi is also a former professor at Berklee College of Music. He earned his MBA at MIT's Sloan School of Management.
Job Titles:
- Senior Scientist, Editor Development
Job Titles:
- Director, External Manufacturing
Job Titles:
- Scientist, Editing Development
Job Titles:
- Associate Scientist, off Target Sciences
Job Titles:
- Associate Scientist, Analytical Development
Job Titles:
- Senior Manager, Stability, External Quality Control
Job Titles:
- Director, Mass Spectrometry
Job Titles:
- Associate Director, Editing Development
Job Titles:
- Engineer, Process Development
Job Titles:
- Senior Vice President of Technical Operations
Jason Politi is the senior vice president of technical operations at Verve Therapeutics. Jason brings 25 years of industry experience in development, manufacturing, and project management. Prior to joining Verve, he served as senior vice president, technical operations at Prevail Therapeutics, where he helped to build and lead the chemistry, manufacturing and controls (CMC) team and managed the company's AAV gene therapy programs. He was instrumental in the approval of Prevail's first three investigational new drug applications with the FDA and the supply for Prevail's clinical trials prior to the company's acquisition by Eli Lilly in 2021. Before Prevail, Jason served as senior director, clinical manufacturing at Alexion. Earlier in his career, he held leadership roles at various biotechnology and pharmaceutical companies, including Dyax, Biogen and AbbVie.
Jason holds a B.S. in Chemical Engineering from the Massachusetts's Institute of Technology and an MBA from Boston College.
Job Titles:
- Associate Director, Financial Planning and Analysis
Job Titles:
- Scientist II, RNA Technology
Job Titles:
- Scientist, Editor Development
Job Titles:
- Senior Director, Clinical Data Management
Job Titles:
- Associate Director, Quality Operations
Job Titles:
- Director, CMC Project Management
Job Titles:
- Vice President, Investor Relations and Corporate Communications
Job Titles:
- Accounts Payable Associate
Job Titles:
- Associate Principal Engineer, Process Development
Job Titles:
- Associate Director, External Manufacturing
Job Titles:
- Director, Human Resources Business Partner
Job Titles:
- Chief Administrative Officer
Joan Nickerson is the chief administrative officer at Verve. She has over 25 years of experience in human resources with more than 12 years of experience in life sciences. Joan previously served as senior vice president, human resources and facilities at Verve since April 2021. Prior to Verve, Joan served as senior vice president, human resources at Sarepta Therapeutics. Previously, Joan held roles of increasing responsibility at Dyax, ultimately serving as senior director of human resources and administrative services.
Joan holds a B.S. in Business Administration from the University of Massachusetts Lowell and an MBA from Simmons College.
Job Titles:
- Senior Manager, Quality Assurance
Job Titles:
- Vice President, Editing Development
Job Titles:
- Senior Associate, Quality Operations
Job Titles:
- Senior Manager, Quality Control
Job Titles:
- Associate Principal Engineer, Process Development
Job Titles:
- Senior IT Service Desk Specialist
Job Titles:
- Executive Director, Human Resources
Job Titles:
- Vice President, Chemistry, Manufacturing & Controls
Job Titles:
- Associate Director, SEC Reporting and Technical Accounting
Job Titles:
- Associate Director, Technology Transfer and Process Engineering
Job Titles:
- Senior Research Associate, Analytics
Job Titles:
- Senior Manager, Accounting
Job Titles:
- Shipping and Receiving Coordinator
Job Titles:
- Engineer, Process Development
Job Titles:
- Associate Scientist, Editing and Discovery
Job Titles:
- Senior Director, Regulatory CMC
Job Titles:
- Member of the Compensation Committee
- Member of the Nominating and Corporate Governance Committee
- Managing Partner, GV
- Member of Compensation Committee Member of Nominating and Corporate Governance Committee
Krishna helps steward the GV investing team and co-leads GV's life sciences group. Krishna led GV's early investments in Flatiron Health, Foundation Medicine, Relay Therapeutics, Beam Therapeutics, insitro, One Medical, and Aledade. He also established GV's incubation program, which helped start companies like ROME Therapeutics and Verve Therapeutics.
Krishna was part of a team that helped in the early days of GV's founding and led the fund's early commitment to invest in life sciences. Earlier in his career, he helped start an electronic data interchange company acquired by Hewlett-Packard and a network security company acquired by Symantec.
Krishna graduated from Harvard's M.D./MBA program where he wrote software to use imaging systems to guide surgical procedures. He went on to serve as an attending in internal medicine at Brigham and Women's Hospital.
Job Titles:
- Principal Scientist, Process Development
Job Titles:
- Laboratory Operations Manager
Job Titles:
- Associate Director, RNA Technology and Sciences
Job Titles:
- Senior Director, External Quality Control
Job Titles:
- Senior Research Associate, Analytics
Job Titles:
- Associate Director, Editing Discovery
Job Titles:
- Associate Principal Scientist, Formulation
Job Titles:
- Director, Regulatory Operations
Job Titles:
- Member of the Audit Committee
- Member of the Nominating and Corporate Governance Committee
Job Titles:
- Scientist, Mass Spectrometry
Job Titles:
- Research Associate, Biophysical Characterization
Job Titles:
- Scientist II, Computational Biology
Job Titles:
- Senior Research Associate, Preclinical Pharmacology
Job Titles:
- Director, GRNA Process Development
Job Titles:
- Director, Process Development
Job Titles:
- Director, Discovery Chemistry
Job Titles:
- Director, Facilities and Lab Operations
Job Titles:
- Senior Director, Regulatory Affairs
Job Titles:
- Associate Director, Toxicology
Job Titles:
- Associate Scientist, Computational Biology
Job Titles:
- Associate Director, Quality Systems
Job Titles:
- Associate Scientist, Editor Development
Job Titles:
- Chairman of the Audit Committee
- Member of the Nominating and Corporate Governance Committee
- Chief Financial Officer and Chief Business Officer, Avidity Biosciences
Job Titles:
- Research Associate, Process Development
Job Titles:
- Network and Security Engineer
Job Titles:
- Manager, Regulatory Affairs
Job Titles:
- Senior Director, Business Development and Corporate Strategy
Job Titles:
- Senior Process Engineer, Formulation
Job Titles:
- Associate Director, Program Management
Job Titles:
- Senior Research Associate, Process Development
Job Titles:
- Research Associate, Bioanalysis
Job Titles:
- Director, Next Generation Sequencing and Automation
Job Titles:
- Senior Research Associate, Analytics
Job Titles:
- Analyst II, Quality Control
Job Titles:
- Senior Research Associate, Analytics
Job Titles:
- Senior Analyst, Quality Control
Job Titles:
- Senior Director, Financial Planning & Analysis
Job Titles:
- Scientist II, Computational Biology
Job Titles:
- Scientist, Editor Development
Job Titles:
- Vice President, Formulation and Analytical Development
Job Titles:
- Senior Research Associate
Job Titles:
- Senior Director, Medical Affairs and Scientific Communications
Job Titles:
- Senior Manager, Logistics
Job Titles:
- Associate Scientist, Editor Development
Job Titles:
- Global Therapeutic Area Head, Infectious Diseases & Vaccines, Janssen Research & Development
Job Titles:
- Associate Director, Analytical Development
Job Titles:
- Manager, Sample and Materials Management
Job Titles:
- Senior Analyst, Quality Control
Job Titles:
- Principal Scientist, Analytical Development
Job Titles:
- Director, LNP Process Development
Job Titles:
- Senior Director, External Manufacturing
Job Titles:
- Senior Director, Formulation Development
Job Titles:
- Vice President, Clinical Operations
Job Titles:
- Executive Director, Preclinical Pharmacology
Job Titles:
- Associate Director, Regulatory CMC
Job Titles:
- Endowed Chair in Pathology and Pathologist, Massachusetts General Hospital Professor of Pathology, Harvard Medical School
Job Titles:
- Senior Manager, IT Applications
Job Titles:
- Associate Director, Quality Operations
Job Titles:
- Scientist I, Preclinical Pharmacology
Job Titles:
- Research Associate, Editing and Discovery
Job Titles:
- Scientist, Discovery Chemistry
Job Titles:
- Senior Research Associate, Next Generation Sequencing
Job Titles:
- Associate Director, Computational Biology
Job Titles:
- Scientist II, Oligonucleotide Chemistry
Job Titles:
- Vice President, Translational Medicine
Job Titles:
- Senior Research Associate, Editor Development
Job Titles:
- Chief Executive Officer
- Co - Founder
- Member of the Board
Job Titles:
- Senior Research Associate, Next Generation Sequencing
Job Titles:
- Research Associate, Computational Biology
Job Titles:
- Member of the Audit Committee
- Member of the Nominating and Corporate Governance Committee
- Co - Founder and Former Chief Executive Officer, AskBio Co - Founder and Chief Executive Officer, Jurata Thin Film
- Member of Audit Committee Member of Nominating and Corporate Governance Committee
Job Titles:
- Scientist, GRNA Technology
Job Titles:
- Principal Scientist, Bioanalysis
Job Titles:
- Director, Chemistry and Formulation
Job Titles:
- Scientist, Editing Discovery
Job Titles:
- Director, Patent Prosecution
Job Titles:
- Associate Director, Biophysical Characterization
Job Titles:
- Director, Quality Operations
Job Titles:
- Research Associate, Bioanalysis
Job Titles:
- Principal Scientist, Preclinical Pharmacology
Job Titles:
- Senior Vice President, Research and Early Development
Job Titles:
- Senior Director, Clinical Scientist
Job Titles:
- Senior Scientist, Editing and Discovery
Job Titles:
- Senior Director, Computational Biology
Job Titles:
- Vice President, Program and Alliance Management
Job Titles:
- Scientist I, Preclinical Pharmacology
Job Titles:
- Director, Discovery Technology Development
Job Titles:
- Scientist II, Computational Biology
Job Titles:
- Automation Engineer, Next Generation Sequencing
Job Titles:
- Director, Clinical Data Management
Job Titles:
- Senior Engineer, Process Development
Job Titles:
- Associate Principal Scientist, Editing Discovery
Job Titles:
- Senior Vice President, Legal Affairs and Chief Intellectual Property Counsel
Job Titles:
- Scientist II, Bioanalysis
Job Titles:
- Senior Scientist, Computational Biology
Job Titles:
- Senior Scientist, Mass Spectrometry
Job Titles:
- Scientist, Editing Discovery
Job Titles:
- Senior Manager, Regulatory Operations
Job Titles:
- Scientist II, Formulation
Job Titles:
- Administrative Coordinator
Job Titles:
- Research Associate, GRNA Technology